Astera Labs Inc (NASDAQ:ALAB) traded at $61.70 at close of the session on Monday, March 10 and made a downward move of -7.80% on its previous day’s price.
Astera Labs Inc has a market cap of $10.00 billion and is expected to release its quarterly earnings report in April.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 151.4M, with a low of 138M and a high of 153.79M. The median projection represents growth squeezing down to 132.00% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 674.89M, or 70.30% up from figures reported last year.
On the other hand, looking at the outlook for the ALAB stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Buy.
Based on estimates by 7 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 1 have rated the Astera Labs Inc (ALAB) stock as a Hold, while 6 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is -23.34% off its SMA20 and -41.01% from its 50-day simple moving average. The RSI (14) is pointing at 29.14 while the volatility over the past week is 8.93% and jumps to 8.24% over the past one month. The beta value is -0.32, while the average true range (ATR) is currently pointing at 7.46. The average price target for the stock over the next 12 months is $100, with the estimates having a low of $74 and a high of $110. These price ends are -19.94% and -78.28% off the current price level respectively, although investors could be excited at the prospect of a -62.07% if the ALAB share price touches on the median price of $100.
